Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
基本信息
- 批准号:8231496
- 负责人:
- 金额:$ 34.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:CaringClinicalClinical DataCorticotropinDataDevelopmentDiseaseEndocrineEndocrinologyEvaluationFunctional disorderFutureGrowthGuidelinesInvestigationKnowledgeLeadLesionLinkMolecularMonitorNeurocognitiveNeurologic DysfunctionsOperative Surgical ProceduresOutcomeOutcome StudyPathologyPatient CarePatientsPituitary GlandPituitary Gland AdenomaPituitary NeoplasmsPlasmaPrevalenceProspective StudiesQualifyingQuality of lifeRecurrenceRecurrent tumorReportingResearch PersonnelResidual stateResourcesRiskRisk FactorsSafetySeriesSpecimenTherapy EvaluationTimeTumor BankTumor Markersbaseclinical careclinical practiceclinically significantcognitive neurosciencecohortfollow-upimprovedmolecular markerneurosurgerynovelprospectivetumortumor growth
项目摘要
PROJECT SUMMARY
This project will conduct the first comprehensive prospective study of clinically non-
functioning pituitary adenomas (CNFA). Current clinical practices for the evaluation, treatment
and follow up of patients with these pituitary adenomas are based on retrospectively collected
data, which have many shortcomings. As a result, significant gaps exist in our knowledge about
how to optimize these practices. A major barrier to improving our approach to these patients has
been the lack of prospectively collected evidence to support or change it. We will overcome this
barrier and answer the important outstanding questions about CNFA care. Aim 1 of this project
is to prospectively study asymptomatic pituitary lesions that do not require surgical intervention
in order to determine the appropriate initial evaluation and follow up as well as the safety of their
conservative, non-surgical management. Aim 2 of this project is to prospectively assess the
outcome of symptomatic CNFAs treated with surgery, the initial treatment of choice.
Recurrences after surgery are common, but cannot be reliably predicted so we will study
potential risk factors for tumor re-growth in particular the "silent" corticotroph tumor type. We will
also assess the safety of conservative follow up for patients with small tumor remnants after
surgery and determine in which of these patients RT is needed by examining the risks vs.
benefits of post-operatively RT for residual/recurrent tumors. Aim 3 of the project is to examine
for the first time, prospectively, the impact of the disease and our therapies on quality of life and
neurocognitive function in patients with CNFAs. Aim 4 of the project will be to establish a novel
bank of pituitary tumor specimens from our cohort that will be linked to the extensive clinical
data collected in our prospective study. This bank will serve as a valuable resource for future
collaborative studies of tumor markers and their clinical significance.
Our investigative team with expertise in Endocrinology, Neurosurgery, Cognitive
Neuroscience and Pathology is well qualified and equipped to undertake this study. The large
number of patients referred to the team make us well situated to conduct this study. The project
is further strengthened by its establishment of a large and unique prospectively followed cohort
of CNFA patients and by its creation of a bank of pituitary tumors that is linked to its clinical
data. This project will provide novel data on the evaluation, treatment and management of
patients with clinically non-functioning pituitary adenomas.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAMELA U FREDA其他文献
PAMELA U FREDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAMELA U FREDA', 18)}}的其他基金
Central Mediation of Growth Hormone Effects in Humans
人类生长激素效应的中枢调节
- 批准号:
10659801 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
9924534 - 财政年份:2017
- 资助金额:
$ 34.51万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
9750716 - 财政年份:2017
- 资助金额:
$ 34.51万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
8500481 - 财政年份:2010
- 资助金额:
$ 34.51万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
8629798 - 财政年份:2010
- 资助金额:
$ 34.51万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
7861520 - 财政年份:2010
- 资助金额:
$ 34.51万 - 项目类别:
Prospective Study of Clinically Non-functioning Pituitary Adenomas
临床无功能垂体腺瘤的前瞻性研究
- 批准号:
8022908 - 财政年份:2010
- 资助金额:
$ 34.51万 - 项目类别:
New Approaches to the Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
7990198 - 财政年份:2009
- 资助金额:
$ 34.51万 - 项目类别:
New Approaches to Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
7477753 - 财政年份:2005
- 资助金额:
$ 34.51万 - 项目类别:
New Approaches to Evaluation and Treatment of Acromegaly
肢端肥大症评估和治疗的新方法
- 批准号:
7279930 - 财政年份:2005
- 资助金额:
$ 34.51万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934920 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934926 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945539 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934927 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945543 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
Core B-Clinical Data Collection and Management Core
核心 B-临床数据收集和管理核心
- 批准号:
10555683 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)
使用数字生物标志物和急诊科电子健康记录中的临床数据对创伤事件暴露后的 PTSD 风险进行护理点预后建模 (PREDICT)
- 批准号:
10884738 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
使用 CTCAE 和其他临床数据分析和解释 PRO-CTCAE,以表征药物耐受性
- 批准号:
10884103 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934921 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
STSS TASK ORDER - NATIONAL CLINICAL DATA COLLABORATIVE (NACDAC)
STSS 任务单 - 国家临床数据协作组织 (NACDAC)
- 批准号:
10949868 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别: